InvestorsHub Logo
Followers 22
Posts 888
Boards Moderated 0
Alias Born 05/09/2012

Re: None

Friday, 11/21/2014 10:37:02 AM

Friday, November 21, 2014 10:37:02 AM

Post# of 18480
What they really need now is a RS and an uplist to a major exchange within the next year. It would be great if they could time this with the release of positive results from the clinical trial they are starting soon (this month?) so it has minimal effect on the SP.

Per the most recent 10-Q, there are 262,713,781 shares outstanding and 500,000,000 shares authorized. They will never climb to the SP they need to be at in order to uplist without a RS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News